TY - JOUR
T1 - The Role of Perivascular Adipose Tissue in the Pathogenesis of Endothelial Dysfunction in Cardiovascular Diseases and Type 2 Diabetes Mellitus
AU - Valentini, Alessia
AU - Cardillo, Carmine
AU - Della Morte, David
AU - Tesauro, Manfredi
PY - 2023
Y1 - 2023
N2 - Cardiovascular diseases (CVDs) and type 2 diabetes mellitus (T2DM) are two of the four major chronic non-communicable diseases (NCDs) representing the leading cause of death worldwide. Several studies demonstrate that endothelial dysfunction (ED) plays a central role in the pathogenesis of these chronic diseases. Although it is well known that systemic chronic inflammation and oxidative stress are primarily involved in the development of ED, recent studies have shown that perivascular adipose tissue (PVAT) is implicated in its pathogenesis, also contributing to the progression of atherosclerosis and to insulin resistance (IR). In this review, we describe the relationship between PVAT and ED, and we also analyse the role of PVAT in the pathogenesis of CVDs and T2DM, further assessing its potential therapeutic target with the aim of restoring normal ED and reducing global cardiovascular risk.
AB - Cardiovascular diseases (CVDs) and type 2 diabetes mellitus (T2DM) are two of the four major chronic non-communicable diseases (NCDs) representing the leading cause of death worldwide. Several studies demonstrate that endothelial dysfunction (ED) plays a central role in the pathogenesis of these chronic diseases. Although it is well known that systemic chronic inflammation and oxidative stress are primarily involved in the development of ED, recent studies have shown that perivascular adipose tissue (PVAT) is implicated in its pathogenesis, also contributing to the progression of atherosclerosis and to insulin resistance (IR). In this review, we describe the relationship between PVAT and ED, and we also analyse the role of PVAT in the pathogenesis of CVDs and T2DM, further assessing its potential therapeutic target with the aim of restoring normal ED and reducing global cardiovascular risk.
KW - cardiovascular diseases (CVDs)
KW - endothelial dysfunction (ED)
KW - type 2 diabetes mellitus (T2DM)
KW - non-communicable diseases (NCDs)
KW - perivascular adipose tissue (PVAT)
KW - insulin resistance (IR)
KW - cardiovascular diseases (CVDs)
KW - endothelial dysfunction (ED)
KW - type 2 diabetes mellitus (T2DM)
KW - non-communicable diseases (NCDs)
KW - perivascular adipose tissue (PVAT)
KW - insulin resistance (IR)
UR - http://hdl.handle.net/10807/303523
U2 - 10.3390/biomedicines11113006
DO - 10.3390/biomedicines11113006
M3 - Article
SN - 2227-9059
VL - 11
SP - N/A-N/A
JO - Biomedicines
JF - Biomedicines
ER -